Closure of patent ductus arteriosus with OcclutechTM device, experience in an andean country

Background and Objective: To communicate the experience in an Andean country with the OcclutechTM Duct Occluder device for the closure of patent ductus arteriosus.

Method: observational, retrospective, cross-sectional study with basic statistical analysis. Period: December/2014 to December/2022. Data: medical chart, reports of catheterization.

Results: Forty-six patients, female 71.3%, male 28.7%; age: 0.6-38 years-old (median [Me]: 5.2); weight: 6.3-60 kg (Me: 16.5). Origin: Andean 91.3%, coast 8.7%. Types of patent ductus arteriosus: E 54.4%, A 32.6%, D 13%. Minimum ductal diameter: 1.8-11.8 mm (Me: 3.5). Mean pulmonary artery pressure prior to occlusion: 14-67 mmHg (Me: 27). Pulmonary vascular resistance index prior to occlusion: 0.28-4.9 WU/m2 (Me: 1.3). Six of them were classified as hypertensive patent ductus arteriosus. Occlusion rate: 47.8% immediate, 81% at 24 hours, 100% after six months. Fluoroscopy time: 2-13.8 minutes (Me: 4). Complications: a migrated device. Follow-up: 1-6.5 years.

Conclusions: OcclutechTM Duct Occluder device was effective and safe for the closure of patent ductus arteriosus type E, A and D in low-altitude and high-altitude dwellers, whether they were children or adults, even when these ductus arteriosus were hypertensive.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:94

Enthalten in:

Archivos de cardiologia de Mexico - 94(2024), 2 vom: 15. Feb., Seite 169-173

Sprache:

Spanisch

Weiterer Titel:

Cierre de conducto arterioso persistente con dispositivo OcclutechTM, experiencia en un país andino

Beteiligte Personen:

Ríos-Méndez, Raúl E [VerfasserIn]
Araúz-Martínez, María E [VerfasserIn]
Oliveros-Rivero, Jorge A [VerfasserIn]
Crespo-Gutiérrez, Yeiber J [VerfasserIn]
Pérez-Vite, Yesenia W [VerfasserIn]

Links:

Volltext

Themen:

Andean
Catheterization
English Abstract
High altitude
Journal Article
Patent ductus arteriosus
Pulmonary hypertension

Anmerkungen:

Date Revised 22.04.2024

published: Electronic

Citation Status In-Process

doi:

10.24875/ACM.23000126

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368495159